A Feasibility Trial of Nivolumab With Neoadjuvant CF or DCF Therapy for Locally Advanced Esophageal Carcinoma

Clinical trial NCT03914443 · COMPLETED

Trial details

NCT number: NCT03914443
Sponsor: National Cancer Center, Japan
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced Esophageal Squamous Cell Carcinoma

Start date: 2019-05-07
Primary completion: 2025-03-31
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.